Linden Advisors’s Hologic HOLX Stock Holding History

Linden Advisors’s Portfolio HOLX Stock Details HOLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-12,980	Closed	-$552K	–	107
2017 Q1	$552K	Buy	+12,980	New	+$529K	0.02%	104
2015 Q3	–	Sell	-25,267	Closed	-$962K	–	79
2015 Q2	$962K	Buy	+25,267	New	+$884K	0.11%	55

Other funds holding HOLX

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Linden Advisors's HOLX Position: Q2 2017 in Review

Linden Advisors sold out of Hologic (HOLX) in Q2 2017, closing a stake of 12,980 shares — an estimated $552K sold.

Linden Advisors first reported a position in HOLX in Q2 2015 and held it in 2 quarters. The position peaked at $962K in Q2 2015. 505 funds tracked by Wall St. Rank hold HOLX as of Q2 2017.

Linden Advisors reported no remaining Hologic position as of Q2 2017 after selling out during the quarter.
Linden Advisors sold 12,980 Hologic shares in Q2 2017, an estimated $552K.
Linden Advisors first reported a position in Hologic in Q2 2015 and held it in 2 quarters.
Linden Advisors's Hologic position peaked at $962K in Q2 2015.
505 funds tracked by Wall St. Rank held Hologic as of Q2 2017.

Based on Linden Advisors's 13F filing for Q2 2017, filed 14 Aug 2017.